Background illustration for clinical trials search

Paid Clinical Trials Orange County

Discover 3,614 paid clinical trials in Orange County, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

for
Neoplasm Metastasis, Non-Small Cell Lung Cancer
Location: Orange CA, Duarte CA, Los Angeles CA, Sacramento CA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT04886804

Phase 1, Recruiting

Lead-212 PSV359 Therapy for Patients With Solid Tumors

for
Pancreatic Ductal Adenocarcinoma, Gastric Cancer,
Location: Los Angeles CA, Dallas TX, Omaha NE, Kansas City KS,
Sponsor: Perspective Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06710756

Phase 1, Phase 2, Recruiting

Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

for
Recessive Dystrophic Epidermolysis Bullosa
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 7+

Code: NCT03392909

Phase 1, Phase 2, Recruiting

Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

for
Bowel; Stricture
Location: Irvine CA, Los Angeles CA, Lancaster CA, San Diego CA,
Sponsor: GIE Medical

Sex: All

Age: 22+

Code: NCT05561127

Phase 3, Recruiting

Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

for
Bladder Carcinoma, Genitourinary System Neoplasm,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05519878

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer

for
Platinum-resistant Ovarian Cancer
Location: Newport Beach CA, El Segundo CA
Sponsor: ImmunityBio, Inc.

Sex: Female

Age: 18 - 70+

Code: NCT06710288

Phase 2, Recruiting

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

for
Heart Failure
Location: Orange CA, Tustin CA, San Dimas CA, Santa Clarita CA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06424288

Phase 3, Recruiting

Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder

for
Opioid Use Disorder
Location: Colton CA
Sponsor: RAND

Sex: All

Age: 18+

Code: NCT06827288

Recruiting

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

for
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV),
Location: Irvine CA, Fullerton CA, Los Angeles CA,
Sponsor: Fate Therapeutics

Sex: All

Age: 12 - 70

Code: NCT06308978

Phase 1, Recruiting

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

for
NSCLC (Advanced Non-small Cell Lung Cancer)
Location: Irvine CA, Los Angeles CA, La Jolla CA, Phoenix AZ,
Sponsor: BlossomHill Therapeutics

Sex: All

Age: 18+

Code: NCT06706076

Phase 1, Phase 2, Recruiting

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

for
Hematologic Malignancy, Solid Tumor, Advanced Malignancies
Location: Los Angeles CA, Chicago IL, Ann Arbor MI,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06401356

Phase 3, Recruiting

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

for
Non-small Cell Lung Cancer (NSCLC)
Location: Burbank CA, Phoenix AZ, Reno NV, Grand Junction CO,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06170788

Phase 3, Recruiting

Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms

for
T-Cell Neoplasm, Lymphoproliferative Disorders
Location: Duarte CA, Ann Arbor MI, Columbus OH, Durham NC
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18+

Code: NCT04858256

Phase 2, Recruiting

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

for
Hypogammaglobulinemia, Bacterial Infections,
Location: Huntington Park CA, Bullhead City AZ, Canton OH,
Sponsor: Grifols Therapeutics LLC

Sex: All

Age: 18+

Code: NCT05645107

Phase 3, Recruiting

Study of ALTO-300 in MDD

for
Major Depressive Disorder
Location: Bellflower CA, Temecula CA, Moorpark CA, Las Vegas NV,
Sponsor: Alto Neuroscience

Sex: All

Age: 18 - 70

Code: NCT05922878

Phase 2, Recruiting

Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer

for
Early-stage Breast Cancer, Breast Carcinoma in Situ,
Location: Santa Monica CA
Sponsor: Saint John's Cancer Institute

Sex: All

Age: 18+

Code: NCT04603209

Recruiting

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Los Angeles CA, Dallas TX, Houston TX, Ann Arbor MI,
Sponsor: LigaChem Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT05941507

Phase 1, Phase 2, Recruiting

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

for
Ovarian Cancer
Location: Burbank CA, La Jolla CA, Palo Alto CA,
Sponsor: Daiichi Sankyo

Sex: Female

Age: 18+

Code: NCT06819007

Phase 3, Recruiting

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

for
Carcinoma, Renal Cell
Location: Orange CA, Palo Alto CA, San Francisco CA, Houston TX,
Sponsor: Oncorena AB

Sex: All

Age: 18+

Code: NCT05287945

Phase 1, Phase 2, Recruiting

Study of ATX-01 in Participants With DM1

for
Myotonic Dystrophy 1
Location: Los Angeles CA, Fairway KS, Iowa City IA,
Sponsor: ARTHEx Biotech S.L.

Sex: All

Age: 18 - 64

Code: NCT06300307

Phase 1, Phase 2, Recruiting